These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 1950379

  • 21. Pathogenesis of feline diabetes mellitus.
    Lutz TA, Rand JS.
    Vet Clin North Am Small Anim Pract; 1995 May; 25(3):527-52. PubMed ID: 7660530
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Role of amylin in the physiologic and physiopathologic regulation of energy metabolism].
    Cooper GJ.
    Journ Annu Diabetol Hotel Dieu; 1991 May; ():125-39. PubMed ID: 1886326
    [No Abstract] [Full Text] [Related]

  • 26. Deficiency of total and nonglycosylated amylin in plasma characterizes subjects with impaired glucose tolerance and type 2 diabetes.
    Mäkimattila S, Fineman MS, Yki-Järvinen H.
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2822-7. PubMed ID: 10946889
    [Abstract] [Full Text] [Related]

  • 27. Spontaneous diabetes in hemizygous human amylin transgenic mice that developed neither islet amyloid nor peripheral insulin resistance.
    Wong WP, Scott DW, Chuang CL, Zhang S, Liu H, Ferreira A, Saafi EL, Choong YS, Cooper GJ.
    Diabetes; 2008 Oct; 57(10):2737-44. PubMed ID: 18633116
    [Abstract] [Full Text] [Related]

  • 28. Basal and stimulated plasma levels of pancreatic amylin indicate its co-secretion with insulin in humans.
    Hartter E, Svoboda T, Ludvik B, Schuller M, Lell B, Kuenburg E, Brunnbauer M, Woloszczuk W, Prager R.
    Diabetologia; 1991 Jan; 34(1):52-4. PubMed ID: 2055340
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Delayed activation of D-glucose transport in type II diabetes mellitus.
    Zeuzem S, Jungmann E, Podda M, Schöffling K, Caspary WF.
    Horm Metab Res Suppl; 1992 Jan; 26():22-4. PubMed ID: 1490687
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Plasma amylin and insulin concentrations in normoglycemic and hyperglycemic cats.
    Lutz TA, Rand JS.
    Can Vet J; 1996 Jan; 37(1):27-34. PubMed ID: 8746416
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. In vivo glucose-stimulated amylin secretion is increased in nondiabetic patients with pancreatic cancer.
    Mäkimattila S, Hietaniemi K, Kiviluoto T, Timonen T, Yki-Järvinen H.
    Metabolism; 2001 Sep; 50(9):1036-42. PubMed ID: 11555835
    [Abstract] [Full Text] [Related]

  • 37. Amylin.
    Edwards BJ, Morley JE.
    Life Sci; 1992 Sep; 51(25):1899-912. PubMed ID: 1453875
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Effects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humans.
    Butler PC, Chou J, Carter WB, Wang YN, Bu BH, Chang D, Chang JK, Rizza RA.
    Diabetes; 1990 Jun; 39(6):752-6. PubMed ID: 2189768
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.